DALLAS, February 1 /PRNewswire/ -- The organizers of the Annual Partnerships in Clinical Trials and Central Labs events present Advanced Biomarker Strategies in Oncology Drug Development. The conference is organized at the Grand Hyatt, San Francisco from February 4-5, 2010. This event is FREE for executives from the biotech and pharmaceutical industries.
This two-day program focuses exclusively on the latest developments in oncology biomarkers. It provides an opportunity to interact with the leaders in clinical R&D, oncology, drug development, and translational research. The program aims to deliver and develop solutions, industry standards, and practical applications for biomarker development and validation. This unique program is the first of our three part Target Clinical Trials Series, delivering therapeutic-specific strategies to facilitate execution of successful clinical trials.
For more information on this event, please visit http://www.iirusa.com/targetbiomarkers.
For more information on the Target Clinical Trial Series, visit http://www.clinicaltrialseries.com.
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.
The Global Biomarker Market report published by MarketsandMarkets analyzes the global biomarker tools and services markets over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.
The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014. Market growth is driven mainly by the high demand for biomarkers in the field of drug discovery; from the increasing demand from the baby boomer generation in the U.S.; and from Asia's emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers.
SCOPE AND FORMAT
The report analyzes the global biomarker market into the following segments:
- Tools Market-(pregenomic biomarkers and technologies, post genomic biomarkers and technologies, imaging biomarkers, and others) - Services Market-(pre- and post-clinical biomarker services, sample preparation, mirna analysis, and others) - Application Market-(diagnosis, and drug development and discovery) Contact Ms. Sunita 7557 Rambler Road, Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 Email: firstname.lastname@example.org
Copyright©2010 PR Newswire.
All rights reserved